Dr Reddys Laboratories (RDY) Receivables - Net (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Receivables - Net of $1.1 billion for Q1 2026, up 1.98% year-over-year from $1.1 billion in Q1 2025, and up 1.98% quarter-over-quarter from $1.1 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Receivables - Net (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Receivables - Net history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Receivables - Net rose 1.98% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 1.98% YoY), while the FY2026 annual figure was $1.1 billion, up 1.98% from the prior year.
- Receivables - Net for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Receivables - Net was $1.1 billion in Q1 2026, with the low at $880.0 million in Q1 2022.
- The 5-year median for Receivables - Net is $939.0 million (2023), against an average of $956.4 million.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net advanced 29.6% in 2022, then advanced 0.34% in 2023.
- Dr Reddys Laboratories' Receivables - Net stood at $893.0 million in 2022, then rose by 5.15% to $939.0 million in 2023, then climbed by 2.56% to $963.0 million in 2024, then increased by 9.87% to $1.1 billion in 2025, then rose by 1.98% to $1.1 billion in 2026.
- Business Quant data shows RDY's Receivables - Net at $1.1 billion in Q1 2026, $1.1 billion in Q1 2025, and $963.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Mar 31, 2024 | 963.00 Mn |
| Mar 31, 2024 | 963.00 Mn |
| Jun 30, 2023 | 939.00 Mn |
| Jun 30, 2023 | 939.00 Mn |
| Mar 31, 2023 | 883.00 Mn |
| Mar 31, 2023 | 883.00 Mn |
| Jun 30, 2022 | 893.00 Mn |
| Jun 30, 2022 | 893.00 Mn |
| Mar 31, 2022 | 880.00 Mn |
| Mar 31, 2022 | 880.00 Mn |
| Mar 31, 2021 | 679.00 Mn |
| Mar 31, 2021 | 679.00 Mn |
| Mar 31, 2020 | 667.00 Mn |
| Mar 31, 2020 | 667.00 Mn |
| Mar 31, 2019 | 576.00 Mn |
| Mar 31, 2019 | 576.00 Mn |